List of Excipients in Branded Drug CITALOPRAM

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Almatica Pharma LLC	CITALOPRAM	citalopram	52427-691	CELLULOSE, MICROCRYSTALLINE
Almatica Pharma LLC	CITALOPRAM	citalopram	52427-691	COPOVIDONE K25-31
Almatica Pharma LLC	CITALOPRAM	citalopram	52427-691	CROSCARMELLOSE SODIUM

Generic Drugs Containing CITALOPRAM

Company	Ingredient	NDC	Excipient
Hikma Pharmaceuticals USA Inc.	citalopram	0054-0062	METHYLPARABEN
Hikma Pharmaceuticals USA Inc.	citalopram	0054-0062	PEPPERMINT
Hikma Pharmaceuticals USA Inc.	citalopram	0054-0062	PROPYLENE GLYCOL

What are the Most Frequently-Used Excipients in CITALOPRAM?

# Of NDCs	Excipient
3	ALUMINUM OXIDE
91	CELLULOSE, MICROCRYSTALLINE
1	CI 77891

Excipient Strategy and Commercial Opportunities for Citalopram

Last updated: March 3, 2026

What are the current excipient strategies for Citalopram formulations?

Citalopram, a selective serotonin reuptake inhibitor (SSRI) used in depression treatment, is primarily marketed as oral tablets and liquids. The formulation process emphasizes the stability, bioavailability, and patient tolerability of the drug.

Common excipients in Citalopram formulations:

• Binders: Microcrystalline cellulose, lactose monohydrate.
• Fillers: Lactose, dibasic calcium phosphate.
• Disintegrants: Crospovidone, croscarmellose sodium.
• Lubricants: Magnesium stearate, stearic acid.
• Coatings: Hypromellose-based film coatings, sometimes with colorants for identification.

Formulation considerations:

• Stability: Excipients like microcrystalline cellulose protect against moisture, oxidation, and pH variations.
• Bioavailability: Excipients such as croscarmellose facilitate rapid disintegration, enhancing absorption.
• Patient acceptability: Flavoring agents are added in liquids; coating modifications reduce bitterness.

Innovation trends:

• Use of disintegrants with lower salt content to reduce gastrointestinal irritation.
• Development of sustained-release formulations utilizing hydrophilic matrix polymers (e.g., hydroxypropyl methylcellulose).
• Incorporation of enteric coatings to prevent degradation in the stomach and improve absorption in the intestine.

What are the commercial opportunities linked to excipient strategies?

Market growth and patent landscape:

• The global antidepressant market exceeds $15 billion annually, with Citalopram accounting for a significant share [1].
• Patent expirations have led to increased generic formulations, intensifying competition.
• Proprietary excipient combinations can provide differentiation, enabling branded generics to command premium pricing.

Opportunities through excipient innovation:

• Enhanced stability formulations extend shelf life, appealing to markets with limited cold chain infrastructure.
• Patient-centric formulations—such as rapidly disintegrating tablets or liquid formulations—expand access for elderly or pediatric populations.
• Sustained-release versions can command higher prices and reduce dosing frequency, thus improving adherence.

Regulatory pathways:

• Identifying novel excipients or new application of existing excipients may trigger opportunities for abbreviated new drug applications (ANDAs) or 505(b)(2) pathways.
• Patent protection may be available through formulation patents that claim specific excipient combinations or release profiles.

Manufacturing efficiencies:

• Optimizing excipient blends can streamline production processes, reduce costs, and improve yields.
• Use of excipients with GRAS (Generally Recognized As Safe) status facilitates faster regulatory approval.

How do excipient choices influence the competitive landscape?

• Differentiation through patented excipient blends creates barriers for generic entrants.
• Innovations that improve bioavailability or patient compliance can position a product as superior, commanding a premium.
• Cost-effective excipient mixes enable competitive pricing, essential in markets with pricing pressures.

Summary table: Excipient options and implications

Excipient Type	Common Use in Citalopram	Commercial Implication
Disintegrants	Crospovidone, croscarmellose	Faster dissolution, market differentiation
Coatings	Hypromellose, colorants	Improved stability, branding
Hydrophilic Polymers	Hydroxypropyl methylcellulose	Sustained-release formulations
Lubricants	Magnesium stearate	Manufacturing efficiency

Conclusion

Citalopram formulations rely on targeted excipient strategies to optimize stability, bioavailability, and patient compliance. Opportunities exist in innovating sustained-release systems, improving stability profiles, and developing patient-friendly formulations. These can provide competitive advantages, particularly amid patent expiries and market competition.

Key Takeaways

• Excipient choices directly affect Citalopram product stability and bioavailability.
• Innovation in formulation can create patentable differentiation opportunities.
• Extended-release and liquid formulations expand market access.
• Cost-efficient excipient use supports competitive pricing.
• Regulatory pathways for novel excipients or formulations present growth prospects.

FAQs

1. What excipients are essential for Citalopram tablet stability?
Microcrystalline cellulose and hypromellose maintain structural integrity and protect against moisture and oxidation.

2. How can excipient innovation improve patient compliance?
By enabling rapid-disintegration, controlled-release, or palatable liquid formulations, excipients enhance adherence.

3. Are there regulatory constraints on excipient choices for Citalopram?
Yes, excipients must meet FDA GRAS status and adhere to pharmacopeial standards, with new excipients requiring safety data.

4. Can proprietary excipient blends extend Citalopram patent life?
Yes, formulation patents utilizing specific excipient combinations or release mechanisms can delay generic entry.

5. What emerging excipient technologies might influence Citalopram formulations?
Bioadhesive polymers, advanced disintegrants, and innovative coatings aimed at targeted release profiles.

References

[1] MarketWatch. (2022). Antidepressant drugs market size, growth, and forecasts. Retrieved from https://www.marketwatch.com